Understanding the Functions of Endogenous and Exogenous Tissue-Type Plasminogen Activator During Stroke-Reference-Cited by-同舟云学术

Understanding the Functions of Endogenous and Exogenous Tissue-Type Plasminogen Activator During Stroke

Published:2015-01 Issue:1 Volume:46 Page:314-320
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Docagne Fabian¹,Parcq Jérôme¹,Lijnen Roger¹,Ali Carine¹,Vivien Denis¹

Affiliation:

1. From the INSERM UMR-S U919 Serine Proteases and Pathophysiology of the Neurovascular Unit, Université Caen Basse Normandie, GIP Cyceron, Caen, France (F.D., J.P., C.A., D.V.); and Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium (R.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference108 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Serine-proteases as plasminogen activators in terms of fibrinolysis

3. Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.;Larsen GR;J Biol Chem,1988

4. Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor–Related Protein-Mediated Transcytosis

5. Glutamate Controls tPA Recycling by Astrocytes, Which in Turn Influences Glutamatergic Signals

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Ischemic Stroke in the Clinic and the Laboratory: Targets for Translational Research;Neuroscience;2024-07

2. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke;Journal of Cerebral Blood Flow & Metabolism;2024-03-04

3. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications;Seminars in Thrombosis and Hemostasis;2024-03-01

4. Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke;Expert Opinion on Drug Metabolism & Toxicology;2024-02

5. Multicenter preclinical analysis of tenecteplase versus alteplase;2023-06-26